Serotonin plays key role in the development of post-bariatric hypoglycaemia
A study conducted at Harvard University has identified the central role of serotonin - a hormone involved in mood regulation - in the...
top of page
Headlines
Serotonin plays key role in the development of post-bariatric hypoglycaemia
A study conducted at Harvard University has identified the central role of serotonin - a hormone involved in mood regulation - in the...
Research
Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy
Fractyl Health has presented new data from its preclinical Rejuva Smart GLP-1 pancreatic gene therapy program in a poster titled,...
Researchers to develop BIOSYNC wireless bioelectronic device to treat obesity and diabetes
A multidisciplinary team led by Ken Shepard, a pioneering researcher in bioelectronics at Columbia Engineering, has won an award of up to...
Serotonin plays key role in the development of post-bariatric hypoglycaemia
A study conducted at Harvard University has identified the central role of serotonin - a hormone involved in mood regulation - in the...
Decline in the number of patients seeking private BMS in the UK
There has been a marked decline in the number of patients seeking private bariatric and metabolic surgery (BMS) in the UK, from 5,900 in...
BioAge axes STRIDES trial evaluating azelaprag in combination with tirzepatide for the treatment of obesity
BioAge Labs is to discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag as monotherapy and in...
Zealand Pharma enrols 1st patient in ZUPREME-1 trial of petrelintide
Zealand Pharma has enrolled the first participant has been enrolled in ZUPREME-1, a global Phase 2b trial in people with obesity or...
Introducing XNY Medical’s next-generation ENDO NOVA Powered Stapler
Bariatric News talked to Dr Jassim Fakhro, Senior Consultant in General, Metabolic, Bariatric and Robotic Surgery, Vice President of the...
SURMOUNT-5: Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%
Eli Lilly and Company has announced topline results from the SURMOUNT-5 phase 3b open-label randomised clinical trial that found Zepbound...
LUCIDITY trial to assess Avexitide in post-bariatric hypoglycaemia patients
Amylyx Pharmaceuticals plans to initiate a Phase 3 LUCIDITY clinical trial for avexitide, an investigational, first-in-class...
Inflatable gastric balloon with controller could help people lose weight
Massachusetts Institute of Technology (MIT) engineers have designed a new type of gastric balloon that can be inflated and deflated as...
Journal Watch 4/12/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Smart Panther Automatic Stapler demonstrates very low rates of bleeding with zero complications in the immediate post-operative period
The Smart Panther Automatic Stapler (Panther Healthcare) is safe and effective with very low rates of bleeding and zero complications in...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
Tweets
bottom of page